HEMOPHILIA A AND B
-
Gene therapy for hemophilia B one step closer: CSL Behring and pCPA agree on pricing
MONTREAL, October 7, 2025 – CSL Behring Canada and the pan-Canadian Pharmaceutical Alliance (pCPA) have announced signing of a Letter of Intent that sets pricing...
-
Update on novel therapies for hemophilia A and B
MONTRÉAL, September 19, 2025 – No announcements have been made over the summer on progress in gaining access to two novel hemophilia therapies. Altuviiio for...
-
WFH mobilizes global community to achieve milestone revisions to WHO EML
While this does not affect Canada directly, it is a major step forward for the international community and acknowledges what Canada is already doing in...
-
CHS research programs: call for applications
The call for applications for the CHS’ research programs for the 2026-2027 grant period is ongoing. The deadline to submit applications for all the programs...
-
CHS educational catalogue
The CHS educational catalogue has been updated. CLICK HERE to take a look at its dynamic online version or to download it as a PDF.